Company: HCTI
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001213900-25-109581
Chunk: 40

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 40
---
 prospectus for its initial public offering filed with the Securities and Exchange Commission (“SEC”).

Overview 

Healthcare Triangle, Inc. (the “Company”)
is a leading healthcare information technology company focused on advancing innovative, industry-transforming solutions in the areas
of cloud services, data science, professional and managed services for the Healthcare and Life Sciences industry.

The Company was formed on October 29, 2019, as
a Nevada corporation and then converted into a Delaware corporation on April 24, 2020, to provide IT and data services to the Healthcare
and Life Sciences (“HCLS”) industry. The business commenced on January 1, 2020, after SecureKloud Technologies Inc, transferred
its Life Sciences business to us. As of September 30, 2025, we had a total of 59 full time employees and 32 sub-contractors, including
42 certified cloud engineers, 21 Epic Certified EHR experts, 12 MEDITECH Certified EHR experts and 3 Admin sub-contractors. Many of the
senior management team and the members of our board of directors hold advanced degrees and some are leading experts in the field of technology,
investment banking and public markets.

During the period ended September 30, 2025, the
Company effected a 1-for 249 reverse split of its issued and outstanding common stock on August 01, 2025. The reverse split reduced the
number of issued and outstanding shares of common stock in proportion to the split ratio, without changing the total authorized shares
or the par value per share.

Our approach leverages our proprietary technology
platforms, extensive industry knowledge, and healthcare domain expertise to provide solutions and services that reinforce healthcare
progress. Through our platform, solutions, and services, we support healthcare delivery organizations, healthcare insurance companies,
pharmaceutical, and Life Sciences, biotech companies, and medical device manufacturers in their efforts to improve data management, develop
analytical insights into their operations, and deliver measurable clinical, financial, and operational improvements.

32

We offer a comprehensive suite of software, solutions,
platforms, and services that enables some of the world’s leading healthcare and pharma organizations to deliver personalized healthcare,
precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to real-world
evidence, and accelerate their digital transformation. We combine our expertise in the healthcare technology domain, cloud technologies,
DevOps and automation, data engineering, advanced analytics, security, compliance,